The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader sector now triggers questions about potential gains. Generic versions are diminishing patent protection , leading to concerns that supporting companies significantly dependent to Viagra's former influence could be a speculative